Sofinnova Investments’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-40,500
Closed -$9.87M 73
2021
Q2
$9.87M Buy
40,500
+1,632
+4% +$401K 0.57% 39
2021
Q1
$9.67M Sell
38,868
-125,795
-76% -$30M 0.58% 35
2020
Q4
$37.9M Buy
164,663
+53,044
+48% +$12.2M 2.25% 9
2020
Q3
$28.4M Buy
+111,619
New +$27.7M 2.1% 12
2019
Q4
Sell
-92,300
Closed -$17.9M 62
2019
Q3
$17.9M Buy
+92,300
New +$17.7M 1.61% 17

Other funds holding AMGN

Sofinnova Investments's AMGN Position: Q3 2021 in Review

Sofinnova Investments sold out of Amgen (AMGN) in Q3 2021, closing a stake of 40,500 shares — an estimated $9.87M sold.

Sofinnova Investments first reported a position in AMGN in Q3 2019 and held it in 5 quarters. The position peaked at $37.9M in Q4 2020. 2,131 funds tracked by Wall St. Rank hold AMGN as of Q3 2021.

  • Sofinnova Investments reported no remaining Amgen position as of Q3 2021 after selling out during the quarter.
  • Sofinnova Investments sold 40,500 Amgen shares in Q3 2021, an estimated $9.87M.
  • Sofinnova Investments first reported a position in Amgen in Q3 2019 and held it in 5 quarters.
  • Sofinnova Investments's Amgen position peaked at $37.9M in Q4 2020.
  • 2,131 funds tracked by Wall St. Rank held Amgen as of Q3 2021.

Based on Sofinnova Investments's 13F filing for Q3 2021, filed 15 Nov 2021.